Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001144204-08-034344

10% owner bought 10,000 shares at $4.21 ($42,071)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Trinad Capital Master Fund Ltd. 10% owner 2008-06-05 Purchase +10,000 $4.21 $42,071 2,258,170 D: show line 1 in the form
Open-market purchases · 10,000 sh · avg $4.21 · $42,071
Loading xslF345X02/v116949_ex.xml…